Moving Towards a Racially Just and Equitable Health Research Enterprise- Thursday, July 2, from 4-5 p.m. ET, online via Zoom
This Community Forum will include three short presentations that explore pathways to more racially just and equitable research practice by examining systemic/structural racism in research.
Learn more how In-Person Non-COVID research protocols will be prioritized to restart within BMC and BU Medical Campus, and find important instructions and required forms.
Community Interventions to Address the Consequences of the COVID-19 Pandemic among Health Disparity and Vulnerable Populations (R01- Clinical Trial Optional)
National Institute on Minority Health and Health Disparities (NIMHD)
Boston Musculoskeletal Clinical Research Collaboratory, a NIAMS funded CCCR will award one grant per year for a project period of 12 months. Funding available: $22,500
Grants will be awarded in support of fellowships and innovative research with potential to improve the lives of those with spinal cord injury and disease (SCI/D) in the following categories: basic science, clinical, design and development, and fellowship.
Grants of up to $600,000 will be awarded in support of the advancement of neuroimaging and CSF biomarkers that can do one or more of the following: engagement for novel therapeutics, detection of signs of disease and monitor progression, and distinguishing between Dementia subtypes.
One-year grants of $50,000 will be awarded in support of new, high-impact clinical, epidemiological, and laboratory glaucoma research projects aligned with the foundation’s strategic goals and overall mission to cure glaucoma and restore vision through innovative research.
Four to six scholars in any discipline will be awarded up to $350,000 over five years. In addition, scholars will receive capacity building and career development opportunities in support of research conducted in one of these areas: reducing inequality and improving the use of research evidence.
News Highlights
Experts Identify Steps to Expand and Improve Antibody Tests in COVID-19 Response
More than 300 scientists and clinicians from the federal government, industry and academia published a report of their conclusions and recommendations on COVID-19 serology studies online in Immunity.
NIH Analytics Platform to Harness Nationwide COVID-19 Patient Data to Speed Treatments
It is part of an effort, called the National COVID Cohort Collaborative (N3C), to help scientists analyze available data to understand the disease and develop treatments.
The data from clinical trial to evaluate the safety and effectiveness of hydroxychloroquine indicate that this drug provided no additional benefit compared to placebo control for the treatment of COVID-19 in hospitalized patients.
